Tesamorelin Reduces Visceral Adipose Tissue and Improves Metabolic Markers in HIV-Positive Patients | RemedyX Labs Research Library

A research summary of Metabolic effects of a growth hormone-releasing factor in patients with HIV, examining tesamorelin reduces visceral adipose tissue and improves metabolic markers in hiv-positive patients. Cited source and RUO context from RemedyX Labs.